Patients with statin resistance do not experience symptoms, Le noted. Instead, the problem is that statins do not lower LDL-C levels as much as they typically do. Instead of a 50% reduction, people ...

Topline data show the Factor XIa inhibitor asundexian lowers recurrent stroke risk vs placebo with no increase in major bleeding events.

Gun violence may hit a historic low this year and trend is coming into focus through those closest to it: the emergency ...

Since 2019, Malaysian primary and secondary schools have reported an average of over 14,000 bullying cases annually.

Ultimately, investigators found a significant reduction in ischemic stroke risk with asundexian compared to placebo, both in combination with antiplatelet therapy. Additionally, participants had no ...

What you need to know In England, 1 in 4 adults,1 and almost 1 in 4 children by the time they are 11 years old,2 are living with obesity (based on body mass index (BMI) measurements and classification ...

The clubs are commended for empowering learners to make informed decisions regarding sex and reproductive health ...

Colon cancer, often overlooked, can manifest on the skin through rashes, nodules, or discolouration, signalling internal ...

AstraZeneca's baxdrostat heads into FDA review after Phase 3 data showed strong blood pressure reductions in adults with hard ...

In the new in the Cardiovascular Health Plan, Czechia wants the Commission to include the latest scientific evidence linking heart, kidney and metabolic diseases ...

Among other things, this should be free of body shaming, idealised body types, and gendered norms, says the world's first Consensus Statement on this ...

AstraZeneca (AZN.L, AZN.ST) secured priority review from the US Food and Drug Administration for its hypertension therapy, ...